Abstract
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea syndrome (OSA) are common conditions that often coexist [Overlap syndrome (OS)]. OS has important implications in the diagnosis, treatment, and patient outcome of both disorders. Patient-reported outcomes (PROs) are essential to evaluate symptoms, impact of symptoms on activities of daily living, and treatment response. The present review aims to display the potential usefulness of PROs measurements (PROMs) regarding the initial evaluation and treatment of both conditions (COPD and OSA) in OS patients. More specifically, we review PROMs regarding symptoms, mental health indices and health-related quality of life in patients with OS. These PROMs have the potential to add value to clinical research and daily practice in certain aspects that are important to patients.
Reference104 articles.
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2022, January 21). Global Strategy for the Diagnosis, Management and Prevention of COPD. Available online: http://www.goldcopd.org.
2. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017;Lancet Respir. Med.,2020
3. Prevalence of obstructive sleep apnea in the general population: A systematic review;Sleep Med. Rev.,2017
4. Voulgaris, A., Archontogeorgis, K., Pataka, A., Flaris, A.N., Ntolios, P., Bonsignore, M.R., Schiza, S., and Steiropoulos, P. (2021). Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome. Medicina, 57.
5. Sleep in chronic obstructive lung disease;Clin. Chest. Med.,1985
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献